Can Chemists Save The World From Chemists?

The Race Is On To Replace Ozone-Eating CFCs. The Entrants: Corporate Giants And Upstart Startups Catalyzed by an international agreement to freeze, and eventually to reduce usage of damaging cholorflourocarbons (CFCs)—and by DuPont Co.’s recent decision to voluntarily comply with the guidelines-the once-cool CFC research arena has transformed into a very hot race. Scientist Michael Hayes, for example, works on the boundaries of matter, studying the reactions that occur between o

Written byGreg Frieherr
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The Race Is On To Replace Ozone-Eating CFCs. The Entrants: Corporate Giants And Upstart Startups

Catalyzed by an international agreement to freeze, and eventually to reduce usage of damaging cholorflourocarbons (CFCs)—and by DuPont Co.’s recent decision to voluntarily comply with the guidelines-the once-cool CFC research arena has transformed into a very hot race.

Scientist Michael Hayes, for example, works on the boundaries of matter, studying the reactions that occur between organic molecules. While most of his past work has been applied in the petroleum business, that has changed during the last two years.

Hayes and his team of researchers at Fernandino Beach, Fla.-based Petroferm are now busy producing a new solvent that may help save the ozone shield and turn a tidy profit for their company.

Petroferm has joined a massive worldwide research ‘effort to develop substitutes for CFCs, which have been used for everything from foaming agents to cleaning ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies